EP2114418A4 - Forme posologique orale stabilisée de picoplatine - Google Patents

Forme posologique orale stabilisée de picoplatine

Info

Publication number
EP2114418A4
EP2114418A4 EP08725393A EP08725393A EP2114418A4 EP 2114418 A4 EP2114418 A4 EP 2114418A4 EP 08725393 A EP08725393 A EP 08725393A EP 08725393 A EP08725393 A EP 08725393A EP 2114418 A4 EP2114418 A4 EP 2114418A4
Authority
EP
European Patent Office
Prior art keywords
picoplatin
dosage form
oral dosage
stabilized oral
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08725393A
Other languages
German (de)
English (en)
Other versions
EP2114418A1 (fr
Inventor
Alistair J Leigh
Christopher A Procyshyn
Ernest S Y Wong
Christen M Giandomenico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Poniard Pharmaceuticals Inc
Original Assignee
Genzyme Corp
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Poniard Pharmaceuticals Inc filed Critical Genzyme Corp
Publication of EP2114418A1 publication Critical patent/EP2114418A1/fr
Publication of EP2114418A4 publication Critical patent/EP2114418A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP08725393A 2007-02-09 2008-02-08 Forme posologique orale stabilisée de picoplatine Withdrawn EP2114418A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88917107P 2007-02-09 2007-02-09
US88968107P 2007-02-13 2007-02-13
PCT/US2008/001752 WO2008097661A1 (fr) 2007-02-09 2008-02-08 Forme posologique orale stabilisée de picoplatine

Publications (2)

Publication Number Publication Date
EP2114418A1 EP2114418A1 (fr) 2009-11-11
EP2114418A4 true EP2114418A4 (fr) 2013-01-09

Family

ID=39682046

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08725393A Withdrawn EP2114418A4 (fr) 2007-02-09 2008-02-08 Forme posologique orale stabilisée de picoplatine

Country Status (12)

Country Link
EP (1) EP2114418A4 (fr)
JP (1) JP2010518089A (fr)
KR (1) KR20090109129A (fr)
CN (2) CN101678046A (fr)
AU (1) AU2008214202A1 (fr)
BR (1) BRPI0806418A2 (fr)
CA (1) CA2677640A1 (fr)
HK (1) HK1206267A1 (fr)
IL (1) IL200262A0 (fr)
MX (1) MX2009008488A (fr)
RU (1) RU2009133446A (fr)
WO (1) WO2008097661A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
WO2010120336A1 (fr) * 2009-04-15 2010-10-21 Poniard Pharmaceuticals, Inc. Thérapie anticancéreuse par voie orale à base de picoplatine à haute biodisponibilité
WO2015179847A1 (fr) * 2014-05-23 2015-11-26 Mingsight Pharmaceuticals, Inc. Traitement d'une maladie auto-immune
CN107778331B (zh) * 2016-08-27 2020-06-30 鲁南制药集团股份有限公司 一种甲啶铂的提纯方法
CN108864177B (zh) * 2018-04-20 2020-07-28 公安部物证鉴定中心 [2h3]-1-甲氨基-2-苯基丙烷的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
ATE348617T1 (de) * 2000-02-16 2007-01-15 Astellas Pharma Inc Heilmittel gegen durch endothelin verursachte erkrankungen
US6939568B2 (en) * 2001-04-23 2005-09-06 Nucryst Pharmaceuticals Corp. Treatment of inflammatory skin conditions
DE10141528B4 (de) * 2001-08-24 2006-08-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung
AU2003220022A1 (en) * 2002-03-01 2003-09-16 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
WO2004006859A2 (fr) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Composes de platine
CN1681478A (zh) * 2002-08-02 2005-10-12 川塞夫有限公司 铂聚集体及其制备方法
AU2005223654A1 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
CN104288119A (zh) 2015-01-21
EP2114418A1 (fr) 2009-11-11
IL200262A0 (en) 2010-04-29
RU2009133446A (ru) 2011-03-20
MX2009008488A (es) 2010-01-15
CN101678046A (zh) 2010-03-24
CA2677640A1 (fr) 2008-08-14
AU2008214202A1 (en) 2008-08-14
WO2008097661A1 (fr) 2008-08-14
KR20090109129A (ko) 2009-10-19
JP2010518089A (ja) 2010-05-27
BRPI0806418A2 (pt) 2011-09-06
HK1206267A1 (en) 2016-01-08

Similar Documents

Publication Publication Date Title
EP2157864A4 (fr) Forme posologique de picoplatine stabilisée
DK2077729T3 (da) Orale probiotiske doseringsformer
LTPA2018014I1 (lt) Farmacinė kompozicija 514
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
BRPI0810928A2 (pt) "composição farmacêutica"
EP2240022A4 (fr) Compositions pharmaceutiques
BRPI0820381A2 (pt) Formulações farmacêuticas
DK2384754T3 (da) Farmaceutiske doseringsformer
EP2321640A4 (fr) Formulation pour une administration orale de protéines
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
EP2124556A4 (fr) Compositions pharmaceutiques
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
EP2373681A4 (fr) Compositions pharmaceutiques
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
EP2310363A4 (fr) Formulation orale anticancéreuse
EP2241304A4 (fr) Composition orale dentaire
EP2236149A4 (fr) Composition médicinale
DK2367542T3 (da) Orale doseringsformer af bendamustin
PT2271348T (pt) Formulação de comprimido oral de composto de tetraciclina
EP2044926A4 (fr) Composition orale pour applications dentaires
BRPI0812964A2 (pt) Forma de dosagem farmacêutica oral sólida
DK2131818T3 (da) Ny doseringsform
IL200262A0 (en) Stabilized picoplatin oral form
DK2271321T3 (da) Farmaceutisk sammensætning 271
DK1837019T3 (da) Orale dispergerbare farmaceutiske sammensætninger

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090908

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121211

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 55/02 20060101ALI20121205BHEP

Ipc: A61K 33/24 20060101AFI20121205BHEP

Ipc: A61K 9/28 20060101ALI20121205BHEP

Ipc: A61K 31/28 20060101ALI20121205BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20130905